11![Q&A GENMAB 4TH OF MARCH 2015 WITH JAN VAN DE WINKEL
Q&A GENMAB 4TH OF MARCH 2015 Q&A GENMAB 4TH OF MARCH 2015 WITH JAN VAN DE WINKEL
Q&A GENMAB 4TH OF MARCH 2015](https://www.pdfsearch.io/img/2bfdd9be6d4abaabac38cc61bf845502.jpg) | Add to Reading ListSource URL: www.proinvestor.comLanguage: English - Date: 2015-03-05 03:24:54
|
---|
12![If you cannot read this mail, click here. August 18, 2009 Amsterdam BioMed News Life Sciences Café - Sign up now! If you cannot read this mail, click here. August 18, 2009 Amsterdam BioMed News Life Sciences Café - Sign up now!](https://www.pdfsearch.io/img/5cc61ee1e77d51b1b6c9781f5dbad8c3.jpg) | Add to Reading ListSource URL: www.amsterdameconomicboard.comLanguage: English - Date: 2015-05-08 08:28:20
|
---|
13![idelalisib 100mg and 150mg tablets (Zydelig®) Gilead Sciences Ltd. SMC No[removed]February 2015 idelalisib 100mg and 150mg tablets (Zydelig®) Gilead Sciences Ltd. SMC No[removed]February 2015](https://www.pdfsearch.io/img/0c939131437e62feb390d0d0540f64f6.jpg) | Add to Reading ListSource URL: www.scottishmedicines.org.ukLanguage: English |
---|
14![JOHN C. BYRD, MD Office Address: Mailing Address: Office: Fax: Lab: JOHN C. BYRD, MD Office Address: Mailing Address: Office: Fax: Lab:](https://www.pdfsearch.io/img/788890f0370bdbe5b4bf9633ddc751cf.jpg) | Add to Reading ListSource URL: osuwmcdigital.osu.eduLanguage: English - Date: 2014-05-01 10:48:22
|
---|
15![pERC deliberated upon the cost effectiveness of ibrutinib compared with a treatment mix reflecting different local standards of care and noted there is currently no single standard of care in Canada in this clinical s
pERC deliberated upon the cost effectiveness of ibrutinib compared with a treatment mix reflecting different local standards of care and noted there is currently no single standard of care in Canada in this clinical s](https://www.pdfsearch.io/img/3dbef8a4b80e4396c516448961a789c7.jpg) | Add to Reading ListSource URL: www.pcodr.caLanguage: English - Date: 2015-01-09 16:28:10
|
---|
16![considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co
considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co](https://www.pdfsearch.io/img/ff309831197993863fe831b37c837510.jpg) | Add to Reading ListSource URL: www.pcodr.caLanguage: English - Date: 2014-12-04 16:10:34
|
---|
17![2143 Index a abatacept 936, 943, 949, 1087, 2027 2143 Index a abatacept 936, 943, 949, 1087, 2027](https://www.pdfsearch.io/img/2aad8d22a8463fb738985db367a206c5.jpg) | Add to Reading ListSource URL: www.wiley-vch.deLanguage: English - Date: 2014-12-22 21:03:20
|
---|
18![Ottobre[removed]Elenchi dei prodotti medicinali per le malattie rare in Europa* Ottobre[removed]Elenchi dei prodotti medicinali per le malattie rare in Europa*](https://www.pdfsearch.io/img/328fa6ea77a4d481639ecb397686afd7.jpg) | Add to Reading ListSource URL: www.orpha.netLanguage: English - Date: 2014-11-03 09:45:01
|
---|
19![Octobre[removed]Listes des médicaments pour les maladies rares en Europe* Octobre[removed]Listes des médicaments pour les maladies rares en Europe*](https://www.pdfsearch.io/img/76140f6d74d39b6ef64ae7b7392d7c27.jpg) | Add to Reading ListSource URL: www.orpha.netLanguage: English - Date: 2014-11-03 09:45:01
|
---|
20![ISF35 Active Immunotherapy for Blood Cancer NIH Protocol #[removed]Phase Ib Study of Autologous Ad-‐ISF35-‐Transduced CLL B Cells and Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Subjects with Fludarabin ISF35 Active Immunotherapy for Blood Cancer NIH Protocol #[removed]Phase Ib Study of Autologous Ad-‐ISF35-‐Transduced CLL B Cells and Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Subjects with Fludarabin](https://www.pdfsearch.io/img/41b27a8a72ce07bec097efadba93911a.jpg) | Add to Reading ListSource URL: osp.od.nih.govLanguage: English - Date: 2013-12-31 14:02:52
|
---|